Qingjuan Ren

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism

Qingjuan Ren, Shuchun Chen, Xing Chen et al. · Drug Design Development and Therapy · 2022 · 86 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

Shu Niu, Shuchun Chen, Xing Chen et al. · Frontiers in Endocrinology · 2022 · 60 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

Xiaoyi Chen, Shuchun Chen, Zelin Li et al. · Frontiers in Pharmacology · 2023 · 27 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice

Lin Yue, Shuchun Chen, Qingjuan Ren et al. · Frontiers in Endocrinology · 2022 · 24 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury

Xiaoyu Pan, Shuchun Chen, Xing Chen et al. · Journal of Diabetes Research · 2022 · 18 citations · Full text

Life Sciences, Genetics, Molecular Biology +17